Benzocaine Gel Toothache Dose-Response Study

PHASE4CompletedINTERVENTIONAL
Enrollment

577

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Toothache
Interventions
DRUG

Placebo gel

single dose (less than 1g) of a matching placebo gel

DRUG

benzocaine

single dose (less than 1g) of 10% benzocaine gel formulation

DRUG

benzocaine

single dose (less than 1g) of 20% benzocaine gel formulation

Trial Locations (8)

10010

Pfizer Investigational Site, New York

21201

Pfizer Investigational Site, Baltimore

48207

Pfizer Investigational Site, Detroit

02111-1527

Pfizer Investigational Site, Boston

14214-3008

Pfizer Investigational Site, Buffalo

43205-2696

Pfizer Investigational Site, Columbus

19104-6030

Pfizer Investigational Site, Philadelphia

15261-0001

Pfizer Investigational Site, Pittsburgh

All Listed Sponsors
collaborator

Church & Dwight Company, Inc.

INDUSTRY

collaborator

Consumer Healthcare Products Association

OTHER

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00474175 - Benzocaine Gel Toothache Dose-Response Study | Biotech Hunter | Biotech Hunter